Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01218100
Other study ID # NEB-MD-25
Secondary ID
Status Completed
Phase Phase 4
First received October 7, 2010
Last updated May 18, 2012
Start date October 2010
Est. completion date June 2011

Study information

Verified date May 2012
Source Forest Laboratories
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

This study will evaluate the safety and efficacy of first-line treatment with a free combination (as two separate pills) of nebivolol and lisinopril in patients with stage 2 diastolic hypertension (DBP>= 100 mmHg).


Recruitment information / eligibility

Status Completed
Enrollment 664
Est. completion date June 2011
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria:

- male and female outpatients 18 to 64 years of age

- Females must be post-menopausal, or not pregnant and using an approved contraceptive regimen

- stage 2 diastolic hypertension (DBP >= 100 mmHg)

Exclusion Criteria:

- secondary hypertension

- evidence of other concurrent disease or conditions that might interfere with the conduct of the study

- participation in an investigational drug study within 30 days or 5 half-lives, whichever is longer, of Screening (Visit 1).

- have a history of hypersensitivity to nebivolol or other ß-blockers, or any contraindication to ß-blocker use

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
nebivolol and lisinopril (free combination)
nebivolol 5-mg and lisinopril 10-mg (nebivolol non-trade 5-mg tablet and overencapsulated lisinopril 10-mg tablet)/QD/oral administration/up to 12 weeks nebivolol 20-mg and lisinopril 40-mg (nebivolol non-trade 20-mg tablet and overencapsulated lisinopril 40-mg tablet)/QD/oral administration/up to 10 weeks nebivolol 5-mg and lisinopril 40-mg (nebivolol non-trade 5-mg tablet and overencapsulated lisinopril 40-mg tablet)/QD/oral administration/up to 6 weeks nebivolol 20-mg and lisinopril 10-mg (nebivolol non-trade 20-mg tablet and overencapsulated lisinopril 10-mg tablet/QD/oral administration/up to 6 weeks
nebivolol monotherapy
nebivolol 5-mg (non-trade 5-mg tablet)/QD/oral administration/up to 12 weeks nebivolol 10-mg (non-trade 10-mg tablet/QD/oral administration/for 1-week down-titration period only) nebivolol 20-mg (non-trade 20-mg tablet)/QD/oral administration/up to 10 weeks
lisinopril monotherapy
lisinopril 10-mg (overencapsulated 10-mg tablet)/QD/oral administration/up to 12 weeks lisinopril 40-mg (overencapsulated 40-mg tablet)/QD/oral administration/up to 10 weeks
placebo
Placebo tablet, oral administration/QD/oral administration/up to 12 weeks Placebo capsule, oral administration/QD/oral administration/up to 12 weeks

Locations

Country Name City State
Puerto Rico Forest Investigative site 044 Caguas
United States Forest Investigative site 065 Asheboro North Carolina
United States Forest Investigative site 062 Ashland Oregon
United States Forest Investigative site 076 Atlanta Georgia
United States Forest Investigative site 069 Balitmore Maryland
United States Forest Investigative site 014 Baltimore Maryland
United States Forest Investigative site 021 Baltimore Maryland
United States Forest Investigative site 019 Boca Raton Florida
United States Forest Investigative site 056 Brandon Florida
United States Forest Investigative site 054 Brockton Massachusetts
United States Forest Investigative site 043 Brooksville Florida
United States Forest Investigative site 011 Broomall Pennsylvania
United States Forest Investigative site 038 Buena Park California
United States Forest Investigative site 075 Burbank California
United States Forest Investigative site 025 Carrollton Texas
United States Forest Investigative site 066 Charleston South Carolina
United States Forest Investigative site 034 Charlotte North Carolina
United States Forest Investigative site 086 Charlotte North Carolina
United States Forest Investigative site 016 Chicago Illinois
United States Forest Investigative site 082 Chicago Illinois
United States Forest Investigative site 085 Chicago Illinois
United States Forest Investigative site 098 Cincinnati Ohio
United States Forest Investigative site 077 Colorado Springs Colorado
United States Forest Investigative site 084 Columbus Ohio
United States Forest Investigative site 042 Costa Mesa California
United States Forest Investigative site 045 Cranston Rhode Island
United States Forest Investigative site 026 Dayton Ohio
United States Forest Investigative site 020 Elizabeth New Jersey
United States Forest Investigative site 052 Fayetteville Tennessee
United States Forest Investigative site 035 Fort Lauderdale Florida
United States Forest Investigative site 028 Fountain Valley California
United States Forest Investigative site 064 Fresno California
United States Forest Investigative site 048 Greer South Carolina
United States Forest Investigative site 002 Hialeah Florida
United States Forest Investigative site 089 Hickory North Carolina
United States Forest Investigative site 094 Hickory North Carolina
United States Forest Investigative Site 070 Honolulu Hawaii
United States Forest Investigative site 006 Houston Texas
United States Forest Investigative site 029 Houston Texas
United States Forest Investigative site 079 Lancaster California
United States Forest Investigative site 010 Las Vegas Nevada
United States Forest Investigative site 012 Las Vegas Nevada
United States Forest Investigative site 027 Lenoir North Carolina
United States Forest Investigative site 097 Long Beach California
United States Forest Investigative site 049 Los Angeles California
United States Forest Investigative site 087 Louisville Kentucky
United States Forest Investigative site 099 Madisonville Kentucky
United States Forest Investigative site 008 Meridian Idaho
United States Forest Investigative site 003 Miami Florida
United States Forest Investigative site 007 Miami Florida
United States Forest Investigative site 057 Miami Florida
United States Forest Investigative site 067 Miami Florida
United States Forest Investigative site 068 Miami Florida
United States Forest Investigative site 039 Morton Illinois
United States Forest Investigative site 093 Mount Pleasant South Carolina
United States Forest Investigative site 030 New Orleans Louisiana
United States Forest Investigative site 009 New Port Richey Florida
United States Forest Investigative site 031 Norfolk Virginia
United States Forest Investigative site 041 Norfolk Virginia
United States Forest Investigative site 053 Norman Oklahoma
United States Forest Investigative site 060 Owensboro Kentucky
United States Forest Investigative site 005 Pembroke Pines Florida
United States Forest Investigative site 036 Pembroke Pines Florida
United States Forest Investigative site 061 Philadelphia Pennsylvania
United States Forest Investigative site 024 Raleigh North Carolina
United States Forest Investigative site 101 Raleigh North Carolina
United States Forest Investigative site 081 Riverside California
United States Forest Investigative site 018 Salt Lake City Utah
United States Forest Investigative site 100 Salt Lake City Utah
United States Forest Investigative site 047 San Antonio Texas
United States Forest Investigative site 071 San Antonio Texas
United States Forest Investigative site 040 San Marino California
United States Forest Investigative site 059 San Ramon California
United States Forest Investigative site 074 Santa Ana California
United States Forest Investigative Site #58 Scottsdale Arizona
United States Forest Investigative site 013 Shelby North Carolina
United States Forest Investigative site 023 St. George Utah
United States Forest Investigative site 095 St. Louis Missouri
United States Forest Investigative site 001 St. Petersburg Florida
United States Forest Investigative site 055 Stockbridge Georgia
United States Forest Investigative site 078 Tacoma Washington
United States Forest Investigative site 004 Tampa Florida
United States Forest Investigative site 046 Tampa Florida
United States Forest Investigative site 080 Tempe Arizona
United States Forest Investigative site 015 Tipton Pennsylvania
United States Forest Investigative site 096 Tucson Arizona
United States Forest Investigative site 072 Tustin California
United States Forest Investigative site 050 Waterbury Connecticut
United States Forest Investigative site 022 Winston-Salem North Carolina
United States Forest Investigative site 051 Zanesville Ohio

Sponsors (1)

Lead Sponsor Collaborator
Forest Laboratories

Countries where clinical trial is conducted

United States,  Puerto Rico, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Change From Baseline in Trough Seated Diastolic Blood Pressure at Week 6. Visit 6/(Week 0) and Visit 9/(Week 6) No
Secondary The Change From Baseline in Trough Seated Systolic Blood Pressure at Week 6. Visit 6/(Week 0) and Visit 9/(Week 6) No